SOPACHEM
ActiveSOPACHEM has been active since 1970 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €427k and a net result of €408k. Equity is growing by ~32.5% per year across the filed fiscal years. Its solvency ranks better than 20% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
65
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▲+13
Solvency43▲+1
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity tight (current ratio 1.23 against 1.12 in 2024; short-term debt: 70.5% and cash: 12.5% of total assets), and 81.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.4%
Return on assets
17.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 64 sector peers (2025).
NBB · sector comparisonPosition among 64 sector peers
Solvency
better than 20%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
21 d early
2024
60 d late
2023
99 d late
2022
29 d late
2021
23 d early
2020
19 d early
2019
15 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Source amounts without an identifiable currency are assumed to be EUR.
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€408k▲ 91.3%
2024 · €213k
2018: €340k
2019: €160k
2020: €877k
2021: €971k
2022: €405k
2023: €407k
2024: €213k
2018 → 2025
Working capital
€367k▲ 32.0%
2024 · €278k
2018: €200k
2019: €200k
2020: €591k
2021: €815k
2022: €1.24M
2023: €1.67M
2024: €278k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€904k-€1.31M▲ 44.8%€1.72M▲ 31.1%€489k▼ 71.5%€427k▼ 12.7%
Operating result€1.09M-€539k▼ 50.5%€528k▼ 2.0%€254k▼ 51.8%€534k▲ 110%
Net result€971k-€405k▼ 58.3%€407k▲ 0.5%€213k▼ 47.7%€408k▲ 91.3%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 110% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.21M
Fixed assets
€211k▲ 56.3%
Current assets
€2.00M▼ 23.7%
Equity and liabilities €2.31M
Equity
€427k▼ 12.7%
Debt
€1.89M▼ 20.9%
The debt ratio falls from 83.0% to 81.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
€598k▲
2024 · €271k
Cash flow
€471k▲
2024 · €230k
Solvency
18.4%▲
2024 · 17.0%
Current ratio
1.23▲
2024 · 1.12
Quick ratio
0.88▼
2024 · 0.95
Debt / equity
4.42▼
2024 · 4.88
ROE
95.6%▲
2024 · 43.6%
ROA
17.6%▲
2024 · 7.4%
Interest coverage
11.57▲
2024 · 6.05
Debt
€1.89M▼
2024 · €2.38M
Debt ≤ 1 year
€1.63M▼
2024 · €2.34M
Debt > 1 year
€228k▲
2024 · €42k
Income taxes
€142k▲
2024 · €74k
Staff costs
€310k▲
2024 · €128k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.87M€2.31M▼
Formation expenses20€118k€104k▼
Fixed assets21/28€135k€211k▲
Intangible fixed assets21€272€46k▲
Tangible fixed assets22/27€103k€133k▲
Furniture and vehicles24€74k€69k▼
Other tangible fixed assets26€29k€65k▲
Financial fixed assets28€32k€31k▼
Current assets29/58€2.62M€2.00M▼
Stocks and contracts in progress3€384k€563k▲
Stocks30/36€384k€563k▲
Amounts receivable within one year40/41€1.24M€977k▼
Trade receivables40€1.16M€892k▼
Other amounts receivable41€83k€85k▲
Cash at bank and in hand54/58€982k€289k▼
Deferred charges and accrued income490/1€9k€168k▲
Equity and liabilities
Total equity and liabilities10/49€2.87M€2.31M▼
Equity10/15€489k€427k▼
Contributions10/11€200k€200k=
Capital10€200k€200k=
Issued capital100€200k€200k=
Reserves13€289k€227k▼
Non-distributable reserves130/1€20k€20k=
Legal reserve130€20k€20k=
Tax-exempt reserves132€7k€7k=
Distributable reserves133€262k€200k▼
Amounts payable17/49€2.38M€1.89M▼
Amounts payable after more than one year17€42k€228k▲
Financial debts170/4€42k€228k▲
Amounts payable within one year42/48€2.34M€1.63M▼
Current portion of amounts payable after more than one year42€19k€77k▲
Trade debts44€685k€723k▲
Suppliers440/4€685k€723k▲
Taxes, remuneration and social security45€193k€42k▼
Taxes450/3€177k€13k▼
Remuneration and social security454/9€15k€29k▲
Other amounts payable47/48€1.44M€788k▼
Accrued charges and deferred income492/3-€28k
Income statement
Code20242025
Non-recurring operating income76A€35k€21k▼
Remuneration, social security and pensions62€128k€310k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17k€64k▲
Other operating charges640/8€10k€10k▲
Non-recurring operating charges66A€35k€25k▼
Gross operating margin9900€444k€943k▲
Operating profit (loss)9901€254k€534k▲
Financial income75/76B€78k€67k▼
Recurring financial income75€78k€67k▼
Financial charges65/66B€45k€52k▲
Recurring financial charges65€45k€52k▲
Profit (loss) for the period before taxes9903€288k€550k▲
Income taxes67/77€74k€142k▲
Profit (loss) for the period9904€213k€408k▲
Profit (loss) for the period to be appropriated9905€213k€408k▲
Appropriation of the result
Profit (loss) to be appropriated9906€213k€408k▲
Transfer from equity791/2€1.44M€62k▼
Transfer to equity691/2€213k-
To other reserves6921€213k-
Profit to be distributed694/7€1.44M€470k▼
Return on contributions (dividend)694€1.44M€470k▼
Social balance
Average headcount (FTE)90871.53.8▲
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 60 days late
2024
07-11
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 99 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
2022
31-12
Financial
Equity above €1MEq €1.31M ▲44.8%
5 profitable years in a row build equity to €1.31M.
08-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €971k ▲10.7%
Operating result €1.09M, net result €971k, both a record.
12-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €500kEq €675k ▲47.8%
3 profitable years in a row build equity to €675k.
16-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Weakest financial yearnet €160k ▼53%
Net result drops to €160k, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
13-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
12 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zwevegem · 2 establishment units since 1970
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Pluim(Z) 208550 ZwevegemGround area
1.6 ha
Building footprint
5,437 m²
Volume, LiDAR
9,386 m³
2 parcels, Flanders · tallest building 9.0 m, ±1 floor. Linked by address, not a title deed.
2 establishment units
Pluim(Z) 20, 8550 Zwevegem
since 19702.004.096.511
Vlamingstraat 4, 8560 Wevelgem
since 20252.376.443.679
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34041C0793/00T002 | Flanders | 8,702 m² | 1 · 2,021 m² | 9.0 m · 1 fl. |
| 34042A1171/00A000 | Flanders | 6,924 m² | 1 · 3,415 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
D2S Pharma
BE 0563.446.868
Oudenaarde · Eq €425k
MERIDIAN BIOSCIENCE EUROPE
BE 0408.081.968
Braine-l'Alleud · Eq €455k
PHARMACIE DE GIVRY
BE 0897.812.697
Quévy · Eq €484k
MY HEALTH INTERNATIONAL
BE 0684.959.659
Lummen · Eq €376k
PROMACON
BE 0444.408.963
Hove · Eq €374k
Of 149 companies in sector 21100 we hold annual accounts for 108. 73 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded16-04-1970
Fiscal year end31-12
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
46851Wholesale of industrial chemicals
51550
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.